---
keywords:
  - 疫苗
comments: true
title: Types of different vaccine
cover_image: 
---

目前市面上的疫苗： 

1. mRNA 疫苗: 關於背後的原理這裡多說，網路一堆資源
2. DNA 疫苗: 
3. 減毒疫苗
4. 次單位疫苗 (subunit)


次單位疫苗在有佐劑幫助下，也有機會藉由樹突細胞Cross-presentation將抗原以MHC-I呈現給T-cell，不過畢竟效率比較差，mRNA及腺病毒載體疫苗能模擬真實病毒感染，在宿主細胞內製造S蛋白時就能順便以MHC-I呈現了~

S-specific T-cell activation

ELISA確認

T-cell activation marker

Phase 2受試者的PBMC

高端才是用CpG喔，Novavax是用他們自家佐劑Matrix-M(基於Saponin。高端是因為Subunit形式本身就比較難引起T-cell response

protein product issue is hard to validate structure correctly.


[Mix-and-match COVID vaccines trigger potent immune response](https://www.nature.com/articles/d41586-021-01359-3)

[A Thermostable mRNA Vaccine against COVID-19](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377714/)

[T cells recognize recent SARS-CoV-2 variants](https://www.nih.gov/news-events/news-releases/t-cells-recognize-recent-sars-cov-2-variants)

[Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19](https://www.nature.com/articles/s41598-020-77077-z)

[FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use)

[FDA briefing materials point to immune bridging studies for pediatric COVID-19 vaccines](https://www.biocentury.com/article/637039/fda-briefing-materials-point-to-immune-bridging-studies-for-pediatric-covid-19-vaccines)

[Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine](https://www.nejm.org/doi/full/10.1056/NEJMoa2026920)

[Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-positive-phase-1-data-its-covid-19-vaccine)

[Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern](https://www.medrxiv.org/content/10.1101/2021.03.19.21254000v1.full)